The CDI mission is to empower research and development in proteomics with proprietary technologies, making possible — today — the protein discoveries of tomorrow. CDI’s HuProt protein microarrays and related services make it possible to perform rapid and efficient analyses of thousands of protein interactions using minimal amounts of valuable research or clinical samples.
The company’s microarray-powered monoclonal antibodies (MAbs] and MAb-related services provide unprecedented levels of specificity. Our system of antibody production is part of the NIH Protein Capture Reagents program and is currently working to produce truly mono-specific antibodies to human transcription factors.
CDI has patents in process for technologies to increase high through put analysis of protein-protein interactions as well as high throughput development of antibodies and identification of biomarkers
At CDI we believe that partnering with both companies and academic scientists is the path to mutual success. So please contact our business development professionals for possible collaborations or partnerships.
The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico.
Contact details
Guanajibo Research and Innovation Park
4005 Street B, Road 114 Km 1.3
Mayaguez, PR 00682
USA
T: 787-806-4010
F: 787-806-4006
www.cdi-lab.com
With over forty years of operations in Puerto Rico, Medtronic is one of the country’s biggest employers. Felix M. Negrón, Vice President of Medtronic Puerto Rico Operations, discusses the affiliate’s…
Over the past few years BMS has consolidated its footprint in Puerto Rico to transform the island into a manufacturing hub for both biopharma and pharmaceuticals. The plant manager of…
Bristol-Myers Squibb (BMS) has made major restructuring changes to its manufacturing processes. Ricardo Zayas, senior vice president of global pharmaceutical manufacturing for BMS, outlines these changes while underscoring the importance of…
Puerto Rico is not only an important manufacturing hub, but is also positioning itself as a state-of-the-art center for R&D and clinical research. Iván Lugo, the executive director of the…
Maribel Rodríguez-Torres of Fundación de Investigación assesses the current R&D situation in Puerto Rico, explains the activities of the center as well as some of their most important success stories. The Fundación is Puerto Rico’s largest research…
Ileana Quiñones, president and general manager of iPR-AstraZeneca, discusses the clear strategy of the affiliate in being a leading manufacturer in Puerto Rico and the steps necessary to ensure their…
Lourdes de Cárdenas, vice president of Stryker’s Latin American operations, explains how she has revamped the Puerto Rican facility to become a more efficient operation and their current vision to…
Yanira Torrellas, president of Quality Consulting Group, details how her company helps the industry through remediation and prevention efforts while highlighting the importance of the service provider sector to collectively…
Rolando Medina, managing director for FedEx Puerto Rico and the Caribbean, highlights the logistics provider’s strong commitment to Puerto Rico’s life science industry through a variety of services and flexible…
John Fernández van Cleve, Chancellor of UPRM, highlights the institution’s strong expertise in engineering and its application in the pharmaceutical and medical device fields. What are some of UPRM’s main…
The Puerto Rico Trade and Export Company (CCE) helps small and medium-sized enterprises (SMEs) stimulate their business in Puerto Rico and abroad. Frankie Chévere, CCE’s executive director, discusses the successes…
The phasing out of fiscal incentives in 2006 has impacted the Puerto Rican economy as well as the life science arena. The president of DDD Group, a company offering fully…
See our Cookie Privacy Policy Here
